🔗 Visit the ClinicalTrials.gov page for NCT00571675
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Drug resistance in metastatic castration-resistant prostate cancer. | Nat Rev Clin Oncol | 2010 | 1.86 |
| 2 | Characterisation and manipulation of docetaxel resistant prostate cancer cell lines. | Mol Cancer | 2011 | 1.32 |
| 3 | Chemosensitization of prostate cancer by modulating Bcl-2 family proteins. | Curr Drug Targets | 2010 | 1.11 |
| 4 | Novel targeted therapeutics for metastatic castration-resistant prostate cancer. | Cancer Lett | 2009 | 1.04 |
| 5 | Overcoming drug resistance and treating advanced prostate cancer. | Curr Drug Targets | 2012 | 0.95 |
| 6 | Emerging molecularly targeted therapies in castration refractory prostate cancer. | Prostate Cancer | 2013 | 0.83 |
| 7 | Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer. | Int J Biol Sci | 2016 | 0.81 |
| 8 | Future directions in castrate-resistant prostate cancer therapy. | Clin Genitourin Cancer | 2010 | 0.79 |